Sign in
4

Changes in Ownership

Nurix Therapeutics, Inc. Filed Acc 0001549595-24-000147

Chief Scientific Officer sold 3,437 shares at $24.31 ($83,536)

  • Chief Scientific Officer acquired 8,957 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Hansen Gwenn · Chief Scientific Officer

Table I: Non-derivative

4 lines
Date Transaction Shares Price Value Owned after D/I
2024-10-30 Exercise or conversion : show line 1 in the form +3,207 48,357 D
2024-10-30 Exercise or conversion : show line 2 in the form +2,000 50,357 D
2024-10-30 Exercise or conversion : show line 3 in the form +3,750 54,107 D
2024-10-30 Sale : show line 4 in the form −3,437 $24.31 $83,536 50,670 D
Open-market sales · 3,437 sh · avg $24.31 · $83,536

Table II: Derivative

3 lines
Date Transaction Shares Owned after D/I
2024-10-30 Exercise or conversion : show line 5 in the form Restricted Stock Units −3,207 16,034 D
2024-10-30 Exercise or conversion : show line 6 in the form Restricted Stock Units −2,000 12,000 D
2024-10-30 Exercise or conversion : show line 7 in the form Restricted Stock Units −3,750 37,500 D
Loading xslF345X05/wk-form4_1730334611.xml…